Delivery Order SPE2DB22D2206-SPE2DB25FKA57
- Not listed
- The Defense Logistics Agency awarded a $1,346.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials. This contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency has awarded a delivery order valued at $2,990.28 to AmerisourceBergen Drug Corp for 100 tablets of Mycophenolate 500 mg, with an ultimate completion date of April 23, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on April 22, 2025. The pharmaceutical product will be delivered to Conshohocken, PA, where AmerisourceBergen Drug Corp maintains its corporate office and primary operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,645.74 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract is unclassified and has no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.68 to AmerisourceBergen Drug Corp for Mycophenolate 200 mg/ml suspension in 160 ml quantities. The contract, awarded July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under a competitive procurement process, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements. The...
- The Defense Logistics Agency awarded a $1,219.46 delivery order to AmerisourceBergen Drug Corp for Mycophenolate 500 mg tablets (100 count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract—which includes no set-aside designation—represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,662.25 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension in 160 mL quantities. The contract, awarded on July 29, 2025, with a completion date of July 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,215.32 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Mycophenolate 250 mg, with a completion date of June 3, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,284.84 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 250 mg capsules (500 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $3,022.37 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension (160 mL) on September 18, 2025, with completion targeted for September 19, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) valued at $5,782.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger federal...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA57Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials, with a ceiling value of $1,066.56. This non-competitive delivery order was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizing firm fixed price pricing. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million through December 2026. The parent contract enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs and other federal healthcare systems worldwide. Mycophenolate, an immunosuppressive medication, represents the type of specialized pharmaceutical product commonly procured through this contract vehicle to support Defense Health Agency operations and military medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/22/25 |